PCIM&H, Ministry of Ayush, Conducts Capacity Building Program on ASU&H Drugs for Regulatory and Quality Professionals
PCIM&H, Ministry of Ayush, Conducts Capacity Building Program on ASU&H Drugs for Regulatory and Quality Professionals
The Pharmacopoeia Commission for Indian Medicine & Homoeopathy, Ministry of Ayush, successfully conducted a five-day Capacity Building Training Program from September 8 to 12, 2025 at its headquarters in Ghaziabad. The program was aimed at strengthening the regulatory framework, quality assurance, and standardisation processes for Ayurveda, Siddha, Unani, and Homoeopathy drugs.
The training brought together 27 participants from across India, representing regulatory bodies, research councils, pharmaceutical industries, and academic institutions. The comprehensive sessions were designed to equip Drug Enforcement Officers, Quality Control Personnel, and drug manufacturers with advanced knowledge and hands-on experience in pharmacopoeial standards and Good Manufacturing Practices.
The program was inaugurated by Prof. (Vaidya) Rakesh Sharma, Former President, Board of Ethics & Registration, NCISM. Dr. Tarkeshwar Jain, Former President, Homoeopathy Education Board, NCH, graced the occasion as Guest of Honour. The inaugural session was led by Dr. Raman Mohan Singh, Director, PCIM&H.
Program Highlights:
Lectures focused on Shelf-life Studies and Regulatory Frameworks, followed by industry visits to Dr. Willmar Schwabe India Pvt. Ltd. (Noida) and Hamdard Laboratories (Ghaziabad), offering real-world exposure.
The valedictory session was graced by Prof. Dr. K. Ramachandra Reddy, Vice Chancellor, Mahayogi Guru Gorakhnath AYUSH University (Chief Guest); Dr. Neelima Mishra, Director, National Institute of Biologicals (Guest of Honour); and Dr. Pankaj Johri, Director, NABP-QCI (Special Guest).
Participants highly appreciated the program’s unique blend of expert-led lectures, practical laboratory sessions, and field visits. The training significantly contributed to enhancing their understanding of Pharmacopoeial Standards, GMP, and Regulatory Compliance, thereby reinforcing the national commitment to ensuring the safety, efficacy, and quality of ASU&H drugs.
